This report summarizes expert consensus reached during discussions regarding design and ethical considerations of Controlled Human...

October 2024 The 3rd Inno4Vac Annual Meeting and its’ Satellite Meetings took place at four locations over four days from 8-11 October...

The third Inno4Vac Subtopic 3 (MERMAID) Regulatory stakeholder meeting- “A regulatory exchange on characterization and qualification of...

On May 21-22 the Inno4Vac interim technical review successfully virtually took place.

Representatives from all partner institutions met to discuss the progress of VAXPRED, the Subtopic 1 of Inno4Vac project

The Inno4Vac project aims to develop advanced and safe Controlled Human Infection Models (CHIMs) that can improve and accelerate vaccine...

January 2024 -Inno4Vac Subtopic 1 (VAXPRED), which is dedicated to building an open access and cloud-based platform to predict vaccine...

January 2024 Inno4Vac sub-topic 4 (VaXinS) aims to develop a hybrid model (a combination of a Compartmental Model [CM] and Kinetic...

October 2023 To advance the ambitious programme of Inno4Vac – which aims to harness the latest advances in immunology, disease modelling,...

October 2023 Subtopic 4 ‘VAXinS’ of Inno4Vac is developing a modular one-stop computational platform for in silico modelling of vaccine...

04 October 2023 The recent 13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (CLOSTPATH), in Banff,...

We are pleased to share the 1st Inno4Vac newsletter where you will find a summary of the communication efforts by EVI over the last few...

August 2023 Inno4Vac announces the nomination of the independent Scientific and Ethics Advisory Committee (SEAC) of the Inno4Vac project....

The 2nd Inno4Vac ST3 (MERMAID) Regulatory stakeholder meeting was held June 27-28 and hosted by the Paul-Ehrlich-Institut in Langen, GE.

16 May 2023 The subtopic1, VAXPRED, dedicated to build an open access and cloud-based platform to predict vaccine efficacy using...

16 November 2022 To advance the ambitious programme of Inno4Vac, which aims to harness the latest advances in immunology and disease...

14 December 2021 The subtopic 2, CHIMICHURRI, dedicated to the development of new and improved Control Human Infection Models (CHIM) for...

29 September 2021 The kick-off meeting of Inno4Vac, a project that targets faster vaccine development and manufacture, by harnessing the...

The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 38.5 million to support Inno4Vac, an innovative...